active pharmaceutical ingredient (API) 活性藥物成分

active pharmaceutical ingredient (API) 
繁: 活性藥物成分
簡: 活性药物成分

無障礙藥物協會（AAM）2月報告指，美國藥房開出的藥品有90%是仿製藥或生物相似藥。其中約一半仿製藥來自印度，且是中國提供這些印度藥80%的活性藥物成分（API）。

美國醫護呻關稅戰或令醫院癱瘓　對華加稅怎導致藥荒？｜新聞背後（2025年4月24日）。香港01，取自https://www.hk01.com/article/60232395?utm_source=01articlecopy&utm_medium=referral

Critical components like active pharmaceutical ingredients (APIs), excipients, packaging materials and processing equipment are now subject to duties, forcing companies to face immediate cost increases, compliance challenges and market uncertainty.  

How Trump’s pharma tariffs disrupt drug supply chains (2025, Apr 21). TechTarget. Retrieved from https://www.techtarget.com/pharmalifesciences/feature/How-Trumps-pharma-tariffs-disrupt-drug-supply-chains